GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 5451 - 5500 of 39437 in total
PDB ID UniProt ID Title ▲ Descriptor
8CA5 O35683 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQ91 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQY9 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQ54 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q99LY9 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 P0DN34 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 O09111 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQH3 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q3UIU2 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CPU2 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQZ6 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9D6J5 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQC7 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CQJ8 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9CR61 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9DCS9 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q9Z1P6 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q8BK30 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
8CA5 Q59J78 Cryo-EM structure NDUFS4 knockout complex I from Mus musculus heart (Class 3).
6MPG Q2N0S6 Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain
6MPG 6MPG Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain
6MPG Q2N0S7 Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain
6CDI Q2N0S5 Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain
6CDI 6CDI Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain
6CDI Q2N0S7 Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain
6MPH 6MPH Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain
6MPH Q2N0S7 Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain
6MPH Q2N0S6 Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain
6CDE Q2N0S7 Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CDE Q2N0S5 Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CDE 6CDE Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6N1V 6N1V Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 17D4 Heavy chain, 17D4 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 Heavy chain, PGT122 Light chain, VRC03 Heavy chain, VRC03 Light chain
6N1V Q2N0S6 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 17D4 Heavy chain, 17D4 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 Heavy chain, PGT122 Light chain, VRC03 Heavy chain, VRC03 Light chain
6CUE Q2N0S7 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CUE Q2N0S6 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CUE 6CUE Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6N1W Q2N0S6 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W 6N1W Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6N1W Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain
6CUF Q2N0S6 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CUF 6CUF Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CUF Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
8B7Q P41160 Cryo-EM structure for the mouse LEPR-CRH2:Leptin:LEPR-Ig complex following symmetry expansion in combination with local refinement
8B7Q P48356 Cryo-EM structure for the mouse LEPR-CRH2:Leptin:LEPR-Ig complex following symmetry expansion in combination with local refinement
7MO8 P14210 Cryo-EM structure of 1:1 c-MET I/HGF I complex after focused 3D refinement of holo-complex
7MO8 P08581 Cryo-EM structure of 1:1 c-MET I/HGF I complex after focused 3D refinement of holo-complex
7LY9 7LY9 Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer
7LY9 A0A0N9FF17 Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer
7MO7 P14210 Cryo-EM structure of 2:2 c-MET/HGF holo-complex
7MO7 P08581 Cryo-EM structure of 2:2 c-MET/HGF holo-complex

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024